PD-L1 Biomarker Testing Market By Product Type (PD-L1 22C3 Assay Kit, PD-L1 SP142 Assay Kit, PD-L1 28-8 Assay Kit, and PD-L1 263 Assay Kit), By Application (Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma, Ovarian Cancer, Melanoma, Haematological Malignancies, Gastrointestinal Tract Malignancy, and Other), By End-user (Hospitals, Cancer Research Institutes, Diagnostic Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Nov 2025
- Report ID: 165929
- Number of Pages: 323
- Format:
-
keyboard_arrow_up
-
-
- Thermo Fisher Scientific Company Profile
- NeoGenomics Laboratories, Inc.
- Merck & Co., Inc.
- Intas Pharmaceuticals
- HalioDx
- Hoffmann-La Roche Ltd.
- Bristol-Myers Squibb
- Agilent Technologies, Inc.
- Abcam plc.
- Abbott Laboratories
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible